ArticleOncoTargets and therapy2017

Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women.

Abdelhabib Semlali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.